The Dutch lab market is liberalising fast, offering big opportunities for international players. Not only that: a private equity house may buy a lab from a not-for-profit hospital early in the New Year. This would be the first of many deals to come. That's especially true now that there is a general political consensus that healthcare and care costs are too high, and that the private sector should be involved in the solution.